FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to N-oxide and/or di-N-oxide derivatives of stabilisers/modulators of dopamine receptors, which have formula (2) (given in description) and to their pharmaceutical preparations, containing said compounds.
EFFECT: invention relates to application of said compounds for treating central nervous system disorders, in particular, for treatment of dopamine-mediated disorders, such as motor disorders, psychoses, anxiety disorders, impaired development of nerves, sleep disorders and disorders, associated with substances.
9 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| 3-SUBSTITUTED 4-(PHENYL-N-ALKYL)-PIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHODS FOR TREATMENT | 2000 |
|
RU2265013C2 |
| SUBSTITUTED 4-(PHENYL-N-ALKYL)PIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT | 2000 |
|
RU2262504C2 |
| NOVEL DOPAMINE NEUROTRANSMISSION MODULATORS | 2000 |
|
RU2386623C2 |
| N-OXIDES AS PRODRUG OF PIPERAZINE AND PIPERIDINE DERIVATIVES | 2006 |
|
RU2394821C2 |
| CHROMONE DERIVATIVES, METHOD FOR PREPARING THEM AND THERAPEUTIC USES THEREOF | 2010 |
|
RU2545214C2 |
| NEW MODULATORS OF CORTICAL DOPAMINERGIC AND GLUTAMATERGIC NEUROTRANSMISSION MEDIATED BY NMDA-RECEPTOR | 2012 |
|
RU2593500C2 |
| OCTAHYDRO-PYRROLO[3,4-b]PYRROL N-OXIDES | 2008 |
|
RU2486187C2 |
| N-SUBSTITUTED DERIVATIVES OF PIPERIDINE AS SEROTONIN RECEPTOR AGENTS | 2003 |
|
RU2320646C2 |
| 3-PHENYL-3-METHOXYPYRROLIDINE DERIVATIVES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION | 2009 |
|
RU2524214C2 |
| COMPOUNDS (R)-5-CARBAMOYL-8-FLUORO-3,N,N-DISUBSTITUTED AMINO-3,4-DIHYDRO-2H-1-BENZOPYRANES, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OF PATIENTS AND METHODS OF SYNTHESIS OF COMPOUNDS | 1994 |
|
RU2142951C1 |
